Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection
- PMID: 38692296
- PMCID: PMC11403456
- DOI: 10.1056/NEJMc2400870
Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV Infection
Figures

Update of
-
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. Update in: N Engl J Med. 2024 May 2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 37486775 Free PMC article. Updated. Clinical Trial.
Similar articles
-
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. Update in: N Engl J Med. 2024 May 2;390(17):1626-1628. doi: 10.1056/NEJMc2400870. PMID: 37486775 Free PMC article. Updated. Clinical Trial.
-
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.JAMA Cardiol. 2024 Apr 1;9(4):323-334. doi: 10.1001/jamacardio.2023.5661. JAMA Cardiol. 2024. PMID: 38381407 Free PMC article.
-
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function.Clin Infect Dis. 2025 Feb 24;80(2):425-433. doi: 10.1093/cid/ciae422. Clin Infect Dis. 2025. PMID: 39159048 Clinical Trial.
-
Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review.Cardiol Rev. 2025 Jul-Aug 01;33(4):374-378. doi: 10.1097/CRD.0000000000000646. Epub 2024 Jan 31. Cardiol Rev. 2025. PMID: 38294226 Review.
-
Pitavastatin (Livalo)--the seventh statin.Med Lett Drugs Ther. 2010 Jul 26;52(1343):57-8. Med Lett Drugs Ther. 2010. PMID: 20651638 Review. No abstract available.
Cited by
-
No evidence of a detrimental effect of pitavastatin on neurocognitive function among people with HIV.AIDS. 2025 Jun 12:10.1097/QAD.0000000000004267. doi: 10.1097/QAD.0000000000004267. Online ahead of print. AIDS. 2025. PMID: 40528406
-
Balancing polypharmacy and comorbidity management: cardiovascular health.Curr Opin HIV AIDS. 2025 Jul 1;20(4):409-415. doi: 10.1097/COH.0000000000000948. Epub 2025 May 13. Curr Opin HIV AIDS. 2025. PMID: 40397570 Review.
-
Association of Cardiac Troponin T With Coronary Atherosclerosis in Asymptomatic Primary Prevention People With HIV.JACC Adv. 2024 Aug 16;3(9):101206. doi: 10.1016/j.jacadv.2024.101206. eCollection 2024 Sep. JACC Adv. 2024. PMID: 39253712 Free PMC article.
-
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized Trial.Ann Intern Med. 2024 Nov;177(11):1449-1461. doi: 10.7326/ANNALS-24-00944. Epub 2024 Oct 8. Ann Intern Med. 2024. PMID: 39374532 Free PMC article. Clinical Trial.
-
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.JAMA Cardiol. 2025 Mar 1;10(3):254-264. doi: 10.1001/jamacardio.2024.4115. JAMA Cardiol. 2025. PMID: 39661372 Clinical Trial.
References
-
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Rockville, MD: NIH Office of AIDS Research, February 2024. (https://clinicalinfo.hiv.gov/en/guide-lines/adult-and-adolescent-arv).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical